M&A Opportunity Viveve recently sold its IP assets to InMode, indicating a potential realignment of partnerships or licensing opportunities for complementary technologies or joint go-to-market strategies with established players in the women's health device space.

Expansion Readiness With a modest revenue base and substantial funding, Viveve may be poised for strategic expansion or partnerships to scale commercialization of its energy-based feminine health solutions in new markets or via larger distributors.

Clinical Validation Ongoing regulatory and clinical activity around SUI devices and related therapies suggests opportunity to offer post-market studies, training programs, or physician education services to support adoption and reimbursement timelines.

Integrated Solutions Existing tech stack and emphasis on education indicate potential to offer scalable digital engagement, tele-education, and facility-centric deployment bundles to clinics and hospitals seeking end-to-end solutions.

Key Personnel Leveraging Leadership and commercial operations hires point to a growth-oriented sales motion; target collaboration around distribution, regional market launches, and accelerated clinician outreach to drive product adoption.